Review Article
AN UP-TO-DATE REVIEW ON THE PHYTOCHEMICAL AND PHARMACOLOGICAL ASPECTS OF THE LAWSONIA INERMIS
A. Batool1, K. Ashiq1,2*, M. Khalid1, A. Munir1, J. Akbar3 and A. Ahmed1
1Faculty of Pharmacy, Superior University Lahore, Pakistan.
2Punjab University College of Pharmacy (PUCP), University of the Punjab Lahore, Pakistan.
3Faculty of Pharmacy, The Islamia University of Bahawalpur (IUB), Pakistan.
Corresponding author kanwal.ashiq@superior.edu.pk and pharmacist.kanwal6@gmail.com
ABSTRACT
Medicinal plants are extensively used throughout the world to treat a variety of ailments because of their safety, efficacy and affordability. Lawsonia inermis or Henna is commonly used in folk medicine for the cure of several illnesses. Particularly, it is used as a hair and hand dye. The objective of this study is to offer the most recent information regarding the pharmacological and phytochemical profile of the medicinal plant that is backed by evidence. Only indexed research and review papers were taken into account for the present study's data gathering in order to ensure authenticity. Only articles published in English language were considered for this study. To conduct a literature survey, various databases such as Scopus, Google Scholar, PubMed, Science Direct, and MEDLINE were searched without any year limit. The following keywords are used to search the data: “Lawsonia inermis”, “medicinal plants”, “herbs”, “phytochemical”, “pharmacological”, “in vivo“, “in vitro”, “Henna” and “toxicity”. The study's findings showed that the plant contains a variety of potent phytochemicals, including Lawsona, linarigenin, linarisenin, luteolin, lawsochrysin, lawsoniaside, lawsonaphthoate e.tc. The fruits, leaves, and stems of L. inermis have all been demonstrated to have potential pharmacological effects in previous investigations. So far, its antioxidant, cytotoxic, antimicrobial, antiprotozoal, immunomodulatory, hypoglycemic, anti-inflammatory, and anticancer properties have been documented. Even though many aspects of the plant have been researched, additional study is still necessary to completely understand the mechanism behind its pharmacological actions, to confirm its medicinal efficacy, and to justify its usage in traditional medicine.
Keywords: Lawsonia inermis, Henna, Medicinal plants, Traditional Medicine, Pharmacological activities
INTRODUCTION
The maintenance and improvement of human health depend greatly on medicinal plants. Natural components found in medicinal plants can aid in the treatment, mitigation, and prevention of disease (Qayyum et al., 2020; Ashiq et al., 2021; Qurat-ul-Ain et al., 2022). The treatment of diseases and toxins by various plants has been documented by all ancient civilizations (Ashiq et al., 2022). The World Health Organization (WHO) claims, the majority of the world's population relies almost entirely on complementary medicines like herbal medications since they are more affordable for patients. In the United States of America (USA), one out of every 25 prescriptions is based on herbal medication, demonstrating the importance of herbal treatment (Latif et al., 2019). Given the significance of medicinal plants, the goal of this study is to provide the most recent, fact-based information on the pharmacological and phytochemical profile of the medicinal plant called Lawsonia inermis.
The plant L. inermis belongs to family Lythraceae. It is a 2-4 meters tall shrub, with smooth, elliptical, oppositely arranged leaves with dorsal placed thin veins. The flowers are delicate, having 4 sepals, white or red stamens and spear-shaped lobed. The henna fruit is a small brown capsule containing 30-40 seeds (Siddiqui et al., 2003; Al-Snafi, 2019). L. inermis can endure extended drought and poor soil conditions and flourishes in a semi-arid, cold climate. L. inermis preserves green leaves in its natural habitat even over prolonged periods of drought; browsing animals that consume the last of their environment's leaves have their lips stained red-orange by the lawsone present in henna leaves (Sharma et al., 2016). During a severe drought, the plant may lose its leaves and go dormant. L. inermis with smaller leaves is thought to be of higher quality and greater potency than with larger leaves. The leaves might be five to six times smaller in the dry season and in dry areas than they are in the rainy season or in wet areas. Wild plants are found river banks and flooded area in rocky areas they may be found in crevices at 1350 meters (Pour et al., 2018).
Taxonomic classification
Kingdom: Plantae
Phylum: Tracheophytes
Class: Angiospermae
Order: Myrtales
Family: Lythraceae
Genus: Lawsonia
Species: Lawsonia inermis
Vernacular names and habitat: Common name of L. inermis is Henna or Hina in Hindi and Arabic. It is also called Egyptian privet, mignonette tree in Jamaica, French Henne, Mehndi in Urdu and Alcana in Spanish. North Africa, Asia, the Middle East, Egypt, America, and Australia are its home continents (Malekzadeh, 1968; Syeda et al., 2020).
Ethnopharmacology: Traditionally, all over the world, henna is applied to hands, feet and hair due to its cooling effect and colouring or dye properties. Especially in marriages people use to apply it on skin for beautiful designing and a cooling effect. That’s why it became popular in hot regions (Bashir et al., 2021). The parts of L. inermis, including leaves, flowers, seeds, stems, bark, and roots are employed to treat numerous illnesses as these parts contain various phytochemicals. In traditional medicine, the plant is used to cure a wide range of illnesses, including inflammation, pain, rheumatoid arthritis, amoebiasis, headache, ulcers, jaundice, diarrhea, leprosy, fever, leucorrhoea, diabetes, anti-hemorrhagic, fungal infections, and cardiac and hepatic diseases. In the past, it was used to treat hair for lice and dandruff. Its oil is said to promote hair growth when applied to balding areas of the body. Further, it was used to stop tissue loss in cases of leprosy, ulcers, and diabetic foot problems. It has astringent and hypotensive properties (Kamal, 2010; Akbar, 2020). The plant is quite effective in treating dysentery. For liver illnesses and related issues, seeds in powered form are given. L. inermis flower extract is used to create fragrances. The bark is used to cure burns and has been given internally to treat calculus, jaundice, and spleen enlargement (Muhammad and Muhammad, 2005). The plant root has an astringent effect and is therefore used in the treatment of irritated eyes. Further, root is also regarded as a powerful treatment for herpes and gonorrhoea. The ethomedicinal uses of the plant are summarized in table 1 (Tutor and Watch, 2017).
Table 1. Pharmacological actions by different parts of L. inermis.
Parts
|
Pharmacological properties
|
Leaves
|
Cough, burning sensation, bronchitis, Hepatopathy, leprosy, Anemia, Astringent ,anti -inflammatory, Constipating , liver tonic, Dysentery, scabies, fever, falling of hair, anti- dandruff ,greyness of hair, ,leprosy, burns, boils ,diarrhea, amenorrhoea,.
|
Bark
|
Enlargement of spleen, skin disorders, leprosy, burning sensation ,jaundice.
|
Seeds
|
Amentia, constipating, diarrohea, intellect promoting, gastrophy ,intermittent fever .
|
Flowers
|
Cardiopathy, insomnia, burning sensation, refragrant agent, amentia, cardiotonic, febrifuge,
|
Roots
|
Skin diseases, burning sensation, amenorrhoea, hair growth, leprosy.
|
MATERIALS AND METHODS
In order to assure validity, only indexed research and review papers were considered for obtaining data. For this study, only publications written in English were taken into consideration. Numerous databases, including Scopus, Google Scholar, PubMed, Science Direct, and MEDLINE, were searched without regard to the year of publication in order to conduct the literature review. “Lawsonia inermis”, “medicinal plants”, “herbs”, “phytochemicals”, “pharmacological”, “in vivo”, “in vitro”, “henna”, and “toxicity” are used as search terms for the collection of the data.
Phytochemicals: A large number of phytochemicals are identified from different parts of plant, the major ones being Lawsone and lawsonoside. L. inermis extracts are notably rich in phenolic chemicals, such as coumarins, flavonoids, and naphthoquinones. The abundance of these constituents implies the importance of the biological activities of the plant against several diseases (Hsouna et al., 2011; Shivsharan and Kothari, 2020). The lawcoumarin was isolated from whole plant. The linarigenin, linarisenin, luteolin, lawsochrysin were isolated from plant leaves (Kebedekidanemariam et al., 2013). Catechin, luteolin, apigenin, genistein were isolated from stems and leaves. Tannic acid is a major constituent of the plant (Siddiqui et al., 2003). The seeds contain fatty acids (10–11%) made up of behenic acid, arachidic acid, stearic acid, palmitic acid, oleic acid, and linoleic acid, as well as proteins (5.0%), carbs (33.62%), fibers (33.5%), and fatty acids (33.5%). Lawsoniaside, lawsonaphthoate, glucosyloxy naphthalene were extracted from the plant's stems and leaves. The naphthalenes are the source of naphthoquinones, which are widely present in L. inermis (Hema et al., 2010). The essential oil produced by the tiny, white, light to dark pink blossoms has a strong scent that is attributed to the presence of β-ionone (Wong and Teng, 1995). Harmine and harmaline were isolated as alkaloids. Fe, Cd, Mn, Cr, Pb, Fe, Ni, Ca, Na, P, K, Mg and Zn were also detected in minor quantities (Boubaya et al., 2011; Saeed et al., 2013). Due to the abundance of pharmacologically potent chemicals in L. inermis, further scientific study is required to back up the claims made for why this plant is used in traditional medicine.
BIOLOGICAL AND PHARMACOLOGICAL EFFECTS
Anti-inflammatory and analgesic activity: Since L. inermis possesses anti-inflammatory properties, it has been recommended for various skin conditions. Rats' inflammation was greatly reduced by L. inermis ethanolic extract (0.25–2.0 g/kg) in a dose-dependent manner (Liou et al., 2013; Raja et al., 2013). Further, 3, 1-5-diphenylpenteen and methyl naphthalene carboxylates were isolated from the plant. The best anti-inflammatory effect was demonstrated by these two isolated molecules (Alia et al., 1995). In an investigation, lawsone was extracted from L. inermis leaves, and its analgesic and anti-inflammatory properties were evaluated, A total of 120 healthy adult mice (weighing around 255 g) were used. Out of the total, 60 mice were used to calculate the LD50, 30 mice were used to calculate the anti-inflammatory test, and the final 30 mice were used to calculate the analgesic test. The analgesic impact was assessed using a hot plate, and the anti-inflammatory effect was assessed by looking at how well the substance reduced swelling and inflammation brought on by the injection of carrageenan. Aspirin and lawsone both had analgesic effects in comparison to the control group. However, lawsone had a stronger analgesic effect than aspirin. Lawsone and aspirin, on the other hand, had an anti-inflammatory effect in comparison to the control group and were equally effective in reducing carrageenan-induced hind paw edema (p = 0.05) (Ali et al., 2022).
Antidiabetic action: Excellent antidiabetic activity was observed by silver nanoparticles of L. inermis extract. In vivo hypoglycemic against wisteria rats showed potent hypoglycemic effects and showed no toxic effects (Kalakotla et al., 2019). In vitro alpha amylase inhibitory activity of methanolic extract of the plant elicited a hypoglycemic effect and also showed potent anti-inflammatory activity (Ashiq and Ashiq, 2021; Imam et al., 2013; Munir et al., 2022).
Hepatoprotective action: For many years, the plant has been utilized for its hepatoprotective action. Aqueous extract of L. inermis was given to albino mice that had carbon tetrachloride 1.25 ml/kg induced liver damage. A considerable reduction in liver damage was seen after administration of the plant extract. The research also indicated that the hepatoprotective effects of the plant extract were dose-dependent. Triterpenes and flavonoids found in the plant extract are responsible for this action (Hossain et al., 2011). Another study of hepatoprotection against paracetamol induced toxicity in rats showed evident reduction in bilirubin, acid phosphatase and other serum enzymes. The extract controlled the amount of marker enzymes and prevented hepatotoxicity. When compared to the control, the ethanolic extract and its fractions decreased the SGOT, SGPT, SAL activity, total bilirubin concentration, and liver weight (Selvanayaki and Ananthi, 2012). Similar studies against drug-induced hepatitis showed protection against drug-induced toxicity and reduced serum leakage (Hasan et al., 2016; Kumar et al., 2017).
Neuroprotective effects: In an investigation, the effect of L. inermis extract on chronic constriction injury (CCI)-induced neuropathic pain was assessed. L. inermis extract (250 mg/kg and 500 mg/kg) and gabapentin (100 mg/kg) were given intraperitoneally for 14 days following the CCI operation. According to the study's conclusions, L. inermis' anti-oxidant and anti-inflammatory activities may have neuroprotective effects against CCI-induced neuropathic pain (Rakhshandeh et al., 2021).
Antioxidant activity: Antioxidant activity is one of the major attributes of L. inermis. The leaves are rich source of antioxidants (Jafarzadeh et al., 2015). The ethanolic extract of plant seeds had good DPPH radical scavenging activity. IC50 of extracts was found to higher (5.4%) as compared to the the standard ascorbic acid drug (Philip et al., 2011). Aqueous and methanolic extracts were found to have a high concentration of phenolic compounds, which were found to be positively correlated with cytoprotective effectiveness against chromium-induced oxidative cellular damage, lipid peroxidation inhibition capability, and radical scavenging potential. Some of the primary phenolic components in both extracts were discovered by HPLC analysis, and they may be the source of both the extracts' antioxidant capability and their DNA and cytoprotective effects (Guha et al., 2011).
Another attempt to distinguish and highlight the antioxidative potential of plant extract by study on soya bean oil stability was conducted by keeping it in storage for 16 days at 63 0C. The methanolic extract at 1400 ppm and synthetic antioxidants, including butylated hydroxyanisole and butylated hydroxytoulene showed same results (200 ppm). The good antioxidant activity was suggested owing to presence of phenolic content in the extract (Hosein and Zinab, 2007). Using the DPPH and ABTS assay, the antioxidant capacities of L. inermis seed extracts in hexane, chloroform, and methanol were evaluated. In the DPPH and ABTS experiments, the methanolic extract demonstrated a higher antioxidant capacity (IC50 = 4.6 mg/l and 3 mg/l, respectively). In chloroform or hexane extracts, no antioxidant activity was found (IC50 > 100 mg/l) (Rafika Chaibi et al., 2017).
Antibacterial activity: The percentage of lawsone in the plant parts ranges from 0.5 to 1.5. The plant's main component, lawsone (2-hydroxynapthoquinone) is what lends its colouring abilities. When compared to a typical antibiotic, the methanol extract showed better anti-bacterial action against Bacillus subtilis, Streptococcus salivarius, Micrococcus, Klebsiella pneumonia, and Streptococcus aureus. The results shown that the hexane extract only efficiently inhibits Streptococcus aureus at high doses. It is highly efficient against B.subtilis and S. salivarius when compared to other species. The chloroform extract is only slightly more effective than the hexane extract, and it works best against Staphylococcus epidermidis and Streptococcus salivarius. The methanol extract is quite potent against all organisms when compared to other extracts (Mastanaiah et al., 2011).
An extensive study on the sequentially extracted flowers, leaves and fruits of L. inermis in DCM, ethanol and ethyl acetate solvents showed excellent antibacterial activity against Eschericha coli, Pseudomonas aeruginosa, Streptococcus subtilis and Staphylococcus aureus in contrast to control drug Streptomycin. Except for the DCM extract of flowers, all other test extracts inhibited all of the test bacteria at a concentration of 60 mg/100 ml. The inhibitory effects varied significantly (P >0.05), and the diameter of the inhibition zone ranged from (9.8 ± 0.4 mm) to (26.7 ± 0.3 mm) (Jeyaseelan et al., 2012). In vitro antibacterial activity against various Gram positive and Gram negative bacteria showed in a dose-dependent way. The plant extract was active at the lowest tested concentration of 7.2% of 62.5 g/ml and 125 g/ml, 5% at the dosage of 250 g/ml, 75.7% at the concentration of 500 g/ml, and 92.8% at the concentration of 1000 g/ml (Arun et al., 2010). The hospital-based antibacterial activity of plant extract at various quantities shown good efficacy against a variety of microorganisms, including the lab standard strain of Pseudomonas aeruginosa (Habbal et al., 2011).
Antifungal activity: L. inermis is traditionally used for the dyeing of hands, feet and hair due to the presence of lawsone that reacts with protein components. But in spite of beautification, it also possesses antifungal properties, hence increasing the hair luster, preventing dandruff on the scalp and locking moisture in the skin. Skin diseases caused by fungus on hands and feet was also lessened due to presence of lawsone ingredient. Commercial lawsone displayed potentially intriguing MICs against the isolates of Aspergillus flavus and Fusarium oxysporum (12 g/mL) respectively. When compared to other extracts, the ethanol extract had the only noteworthy MIC (230 g/mL of crude extract) against the strain F. oxysporum (Rahmoun et al., 2013). Another study of different extracts of L. inermis against dermatophytes strains Trichophyton and Microsporum showed that aquesous extract was most effective compared to chloroform or methanol extracts. At the highest concentration 100 mg/ml most potent antifungal action of L. inermis (26 mm against M. fulvum) was exhibited by the aqueous extract (Sharma et al., 2011). Trichophyton mentagrophytes and T. violaceum are more susceptible to ethanol extract with a MIC of 7.5 mg/ml, according to another dermatophyton activity. However, ethanolic extract at a dosage of 10 mg/ml was found to be toxic to all Trichophyton species (Suleiman and Mohamed, 2014). Further, derivatization from lawsone to substituted napthaquinones gave compounds that showed excellent antifungal results against Curvularia lunata and Fusarium oxysporum at all concentrations i.e. 120 mg/ml, 360 mg/ml and 600 mg/ml. Even at the lowest dose of 120 mg/ml, there was a significant proportion of spore germination inhibition (Brahmeshwari et al., 2012).
Wound healing properties: The L. inermis plant has been shown to have wound-healing qualities through traditional applications. The plant's anti-bacterial and antifungal properties make it particularly effective at healing burn wounds. The mice model with excision, incision wounds compared to placebo control experiments revealed that the extract treated animals demonstrated a faster rate of epithelialization (12.4 ±0.13, days). The histological studies of the tissue obtained from the L. inermis treated group showed a significant increase in collagen deposition, few macrophages, reduction in tissue edema, and more fibroblasts. Hence, it was validated from the study that the plant has potential to promote wound healing (Nayak et al., 2007). In another study, the epidermal regeneration that covers the entire surface of the lesion treated with henna oil was dyed to look into the organization of the epithelium and tissue. The scar zones that had been treated with oil under a microscope revealed complete, coordinated epidermal regeneration and increased thickness, which was regarded as normal (Rekik et al., 2019). A formulation based study of wound healing consisted of L. inermis ointment was also conducted. Animals treated with ointment demonstrated greater wound contraction (14%) than those of the control group (14%) (Yassine et al., 2020). The main phytochemicals involved in wound healing are coumarins, flavonoids, tannins, and alkaloids. Additionally, the plant promotes wound healing because it contains antioxidants that lessen malondialdehyde, lower the ratio of lipid peroxidation, and reduce RNA and DNA oxidation (Daemi et al., 2019).
Anti-Alzheimer activity: Recently, an extensive study has been done to estimate the in vitro anticholinestrase activity (R Chaibi, Romdhane, Ferchichi, & Bouajila, 2015) for treatment of cognitive impairment in patients with Alzheimer’s disease against the standard drug donepezil. The presence of oleanic acid, beta sitosterol and acetyloleonic acid indicated potent and selective anti-Alzheimer’s activity and the results further verified by docking studies (Balaei-Kahnamoei et al., 2021)
Antimalarial activity: The activity of petroleum ether and ethyl extracts against Plasmodium falciparum was investigated. Extracts showed somewhat antimalarial activity with IC50 of 35.5 mg/ml (Babili et al., 2013). Nanoparticles of leaf extract gave excellent activity against all microbes and some species of plasmodium along with good antioxidant activity. The synthesis was time efficient and the results were comparable to the standard drug (Ajitha et al., 2016). Another study was conducted against Plasmodium berghei and results demonstrated an excellent in vitro activity of L. inermis extract as compared to the other plants’ extracts. The average chemosupressive percentage of L. inermis was found to be 61.57% (Deborah et al., 2020).
Anticancer activity: Dalton’s lymphoma ascites was induced in selected groups of mice and a dose of 180 mg/kg of plant extract was administered for 15 days and results were compared to vincristine. Light microscopy has been used to assess the histopathology of several liver segments from control and experimental animals. Cell line (DLA) generated mice's liver sections revealed structural changes to the nucleus. The main changes were loss of hepatocytes, and injury to the central vein. The L. inermis root extract therapy partially repairs this injury. Histopathological findings following DLA administration revealed that the treatment with an ethanolic root extract of the plant replenishes this damage (Priya et al., 2011). With the advancement in technology, the nanoparticles of L. inermis extracts are being made and tested against several cancer cell lines (Babili et al., 2013). Zinc ferrite nanoparticle of the extract was studied against breast cancer cell lines with a 25–500 µg/ml concentration range. The results showed that there is a gradual decrease in cell viability with increase in the concentration of ZnFe2O4 nanoparticles (Sarala et al., 2020). Another recent study with zinc oxide nanoparticles of plant extract on hep-G cells and quantom dots method showed a significant antimalarial and anticancerous activity however, further research is still required (Amuthavalli et al., 2021).
Sickle cell anemia activity: In the country of Oman, sickle cell anemia is a frequent condition. Cells with a sickle shape develop in this illness. These cells block blood vessels, which reduces the amount of oxygen carried by the blood. It has been established that L. inermis can prevent sickle cell development. Lawsone (2-Hydroxy-1,4-Naphthoquinone), a component of L. inermis, is what gives the dye its anti-sickling properties by making red blood cells more oxygen-affine. L. inermis contains anti-sickling properties, which have been demonstrated by combining sickle cell disease patient whole blood with aqueous and methanolic L. inermis extracts. Sodium bisulphite was then added to reduce the oxygen tension to 2%. As a result, the ratio of sickle cells to healthy red blood cells was assessed every 30 minutes. Sodium bisulphite was then added to reduce the oxygen tension to 2%. As a result, the ratio of sickle cells to healthy red blood cells was assessed every 30 minutes. In 84% of the analyzed samples, henna showed to slow the sickling process. Aqueous and methanolic henna extracts can both postpone sickling for roughly an hour (Kumar et al., 2021).
Toxicity: A case report on a young adolescent girl with 6GDP deficiency showed nausea, vomiting and severe toxicity after ingestion of a concentrated methanolic extract of L. inermis (Perinet et al., 2011; Sagh et al., 2022). Further studies on groups showed abortifacient effects of plant extracts (Kandil et al., 1996; Soker et al., 2000; Ilkhanipur and Hakimian, 2013). Another aspect of the study was the induction of hemolytic anemia which leads to life threatening situations and teratogenicity (Mura et al., 2009; Ilkhanipur and Hakimian, 2013). Another toxic effect of plant extract observed is allergic reaction to patients upon contact with skin (Treister-Goltzman et al., 2016). Further, the Scientific Committees on Consumer Products and Consumer Safety reports to the European Commission give an overview of the extensive toxicity studies conducted on L. inermis, which were necessary for product registration. Henna's median oral lethal dosage was determined during an acute toxicity study to be above 2000 mg/kg b.w. in Sprague-Dawley rats, and its median dermal lethal dose was similarly over 2000 mg/kg b.w. in Wistar rats (Semwal et al., 2014).
Conclusion: The miraculous herb has a large number of advantageous active pharmacological elements that are responsible for the plant's wide range of therapeutic capabilities. The rationale for its use in conventional treatments has been elucidated and supported by numerous investigations. Additionally, safety analyses necessary for the licensing of henna products indicate that L. inermis does not seem to have acute or chronic toxicity; nonetheless, this safety status is still under consideration. More research is required to completely understand the mechanism underlying the plant’s pharmacological actions. Furthermore, it is suggested, to validate and support the use of the herb in traditional medicine as well as to demonstrate its safety and effectiveness, further exploratory studies are still needed.
Funding: None
Conflict of interest: There is no conflict of interest among the authors.
REFERENCES
- Ajitha, B., Y. A. K. Reddy, P.S. Reddy, Y. Suneetha, H. J. Jeon and C.W. Ahn (2016). Instant biosynthesis of silver nanoparticles using Lawsonia inermis leaf extract: Innate catalytic, antimicrobial and antioxidant activities. J. Mol. Liq. 219: 474-481. https://doi.org/10.1016/j.molliq.2016.03.041.
- Akbar, S. (2020). Lawsonia inermis(Lythraceae) Handbook of 200 Medicinal Plants. Springer. 1085-1093 p.
- Al-Snafi, A. (2019). A review on Lawsonia inermis: A potential medicinal plant. I. J. Curr. Pharm. Res. 11(5): 1-13.
- Ali Talab, T., N. Alfuraiji and A. E. Al-Snafi (2022). The Analgesic and Anti-Inflammatory Effect of Lawsone Isolated from Lawsonia inermis. Pharm. Sci. 1(35): 77-84.
- Alia, B., A. Bashir and M. Tanira (1995). Anti-inflammatory, antipyretic, and analgesic effects of Lawsonia inermis(henna) in rats. Pharmacol. 51(6): 356-363. https://doi.org/10.1159/000139347.
- Amuthavalli, P., J. S. Hwang, H. U. Dahms, L. Wang, J. Anitha, M. Vasanthakumaran and M. Paulpandi (2021). Zinc oxide nanoparticles using plant Lawsonia inermis and their mosquitocidal, antimicrobial, anticancer applications showing moderate side effects. Sci. Rep. 11(1): 1-13. https://doi.org/10.1038/s41598-021-88164-0.
- Arun, P., K. Purushotham, J. Jayarani and K. Vasantha (2010). In vitro antibacterial activity and flavonoid contents of Lawsonia inermis (Henna). Int. J. Pharm. Tech. Res. 2(2): 1178-1181.
- Ashiq, K., K. Hussain, M. Islam, N. Shehzadi, E. Ali and S. Ashiq. (2021). Medicinal plants of Pakistan and their xanthine oxidase inhibition activity to treat gout: a systematic review. Turk. J. Bot. 45(8): 723-738. https://doi.org/10.3906/bot-2109-19.
- Ashiq, K., M. Qayyum, M. A. Bajwa, S. Ashiq, F. Abid and S. Yasir (2022). Assessment of pharmacists towards the use of herbal medicines in Lahore, Pakistan. Rawal. Med. J. 47(3): 684-684.
- Ashiq, S and K. Ashiq. (2021). Potential role of gut microbiota in obesity and cardiovascular diseases. Pak. Heart. J. 54(3): 207-213.
- Babili, F., A. Valentin and C. Chatelain (2013). Lawsonia inermis: its anatomy and its antimalarial, antioxidant and human breast cancer cells MCF7 activities. Pharm. Anal. Acta. 4 (203): 2. https://doi.org/10.4172/2153-2435.1000203
- Balaei-Kahnamoei, M., M. Saeedi, A. Rastegari, M.R. Shams Ardekani, T. Akbarzadeh and M. Khanavi (2021). Phytochemical analysis and evaluation of biological activity of Lawsonia inermis Seeds related to Alzheimer’s disease. -based Complement. Altern. Med. 2021. https://doi.org/10.1155/2021/5965061.
- Bashir, F., K. Sultana, M. Khalid and H. Rabia (2021). Kojic acid: a comprehensive review. Asian. J. Allied. Health. Sci. 6(1): 13-21.
- Boubaya, A., N. Marzougui, L.B. Yahia and A. Ferchichi (2011). Chemical diversity analysis of Tunisian Lawsonia inermis populations. African. J. Biotechnol. 10(25): 4980-4987.
- Brahmeshwari, G., M. Surekha and K. Saini (2012). Antifungal activity of naphthothiazoles derived from Lawsone (Lawsonia inermis). African. J. Biotechnol. 11(78): 14405-14409.
- Chaibi, R., S. Drine and A. Ferchichi (2017). Chemical study and biological activities of various extracts from Lawsonia inermis (Henna) seeds. Acta. Medica. Mediterr. 33: 981-986. http://dx.doi.org/10.19193/0393-6384_2017_6_155.
- Chaibi, R., M. Romdhane, A. Ferchichi and J. Bouajila (2015). Assessment of antioxidant, anti-inflammatory, anti-cholinesterase and cytotoxic activities of Henna (Lawsonia inermis) flowers. J. Nat. Prod. 8: 85-92.
- Daemi, A., M.R. Farahpour, A. Oryan, S. Karimzadeh and E. Tajer (2019). Topical administration of hydroethanolic extract of Lawsonia inermis (henna) accelerates excisional wound healing process by reducing tissue inflammation and amplifying glucose uptake. Kaohsiung. J. Med. Sci. 35(1): 24-32. https://doi.org/10.1002/kjm2.12005.
- Deborah, A. F. I., O. Aanuoluwapo and F. Ebunoluwa (2020). Comparative In Vivo antiplasmodial activities of different extracts of Lawsonia inermis, Tithonia diversifolia and Nauclea latifolia against Plasmodium berghei. African. J. Bio. Sci. 2(1): 9-17.
- Guha, G., V. Rajkumar, R.A. Kumar and L. Mathew (2011). Antioxidant activity of Lawsonia inermis extracts inhibits chromium (VI)-induced cellular and DNA toxicity. Evid. Based. Complement. Alter. Med. 2011. https://doi.org/10.1093/ecam/nep205.
- Habbal, O., S. Hasson, A. El-Hag, Z. Al-Mahrooqi, N. Al-Hashmi, Z. Al-Bimani and A. Al-Jabri (2011). Antibacterial activity of Lawsonia inermis Linn (Henna) against Pseudomonas aeruginosa. Asian. Pacific. J. Tropic. Biomed. 1(3): 173-176. https://doi.org/10.1016/S2221-1691(11)60021-X.
- Hasan, K. M., S. Yesmin, S.F. Akhter, S. Paul, S. Sarker, A. Islam and M. R. I. Khan (2016). Hepatoprotective potentiality of various fractions of ethanolic extracts of Lawsonia inermis (henna) leaves against chemical-induced hepatitis in rats. Biochem. Mol. Biol. 1(2): 17-22.
- Hema, R., S. Kumaravel, S. Gomathi and C. Sivasubramaniam (2010). Gas chromatography-Mass Spectroscopic analysis of Lawsonia inermis Life. Sci. J. 7: 48-50.
- Hosein, H. K. M and D. Zinab (2007). Phenolic compounds and antioxidant activity of henna leaves extracts (Lawsonia inermis). World. J. Dairy. Food. Sci. 2(1): 38-41.
- Hossain, C. M., H.S. Maji and P. Chakraborty (2011). Hepatoprotective activity of Lawsonia inermis Linn, warm aqueous extract in carbon tetrachloride induced hepatic injury in Wister rats. Asian. J. Pharm. Clin. Res. 4(3): 106-109.
- Hsouna, A. B., M. Trigu, G. Culioli, Y. Blache and S. Jaoua (2011). Antioxidant constituents from Lawsonia inermis leaves: Isolation, structure elucidation and antioxidative capacity. Food. Chem. 125(1): 193-200. https://doi.org/10.1016/j.foodchem.2010.08.060.
- Ilkhanipur, H and Hakimian, N. (2013). Henna: A cause of life threatening hemolysis in G6PD-deficient patient. Pak. J. Med. Sci. 29 (1) Suppl: 429-431. http://dx.doi.org/10.12669/pjms.291(Suppl).3549.
- Imam, H., N. U. Mahbub, M. F. Khan, H. K. Hana and M. Sarker (2013). Alpha amylase enzyme inhibitory and anti-inflammatory effect of Lawsonia inermis. Pak. J. Bio. Sci. 16(23): 1796-1800. https://doi.org/10.3923/pjbs.2013.1796.1800.
- Jafarzadeh, L., N. Seifi, N. Shahinfard, M. Sedighi, S. Kheiri, H. Shirzad and M. Rafieian-Kopaei (2015). Antioxidant activity and teratogenicity evaluation of Lawsonia inermis in BALB/c mice. J. Clin. Diagnos. Res. 9(5): FF01. https://doi.org/10.7860%2FJCDR%2F2015%2F12290.5911.
- Jeyaseelan, E. C., S. Jenothiny, M. Pathmanathan and J. Jeyadevan (2012). Antibacterial activity of sequentially extracted organic solvent extracts of fruits, flowers and leaves of Lawsonia inermis from Jaffna. Asian. Pacific. J. Tropic. Biomed. 2(10): 798-802. https://doi.org/10.1016/S2221-1691(12)60232-9.
- Kalakotla, S., N. Jayarambabu, G.K. Mohan, R. B. S. Mydin and V.R. Gupta (2019). A novel pharmacological approach of herbal mediated cerium oxide and silver nanoparticles with improved biomedical activity in comparison with Lawsonia inermis. Colloid. Surf. B. Biointerfaces. 174: 199-206. https://doi.org/10.1016/j.colsurfb.2018.11.014.
- Kamal, M. (2010). Pharmacological activities of Lawsonia inermis: a review. Int. J. Biomed. Res. 15(4): 2139-2151.
- Kandil, H., H. Al-Ghanem, M. M, M. A. Sarwat and F. S. Al-Thallab (1996). Henna (Lawsonia inermis) inducing haemolysis among G6PD-deficient newborns. A new clinical observation. Ann. Trop. Paediatr. 16(4): 287-291. https://doi.org/10.1080/02724936.1996.11747840.
- Kebedekidanemariam, T., T. K. Tesema, K. H. Asressu and A. D. Boru (2013). Chemical investigation of Lawsonia inermis leaves from Afar region, Ethiopia. Orient J. Chem. 29(3): 1129-1134.
- Kumar, K., N. Kumar, P. Swarnima and A. Siddiqui, (2021). Henna (Lawsonia inermis) a medicinal herb effective in sickle cell disease. Int. J. Indig. Herb. Drug. 6(1): 1-4. https://doi.org/10.46956/ijihd.vi.110.
- Kumar, M., P. Kaur, M. Chandel, A. P. Singh, A. Jain and S. Kaur (2017). Antioxidant and hepatoprotective potential of Lawsonia inermis leaves against 2-acetylaminofluorene induced hepatic damage in male Wistar rats. BMC Complement. Altern. Med. 17(1): 1-11. https://doi.org/10.1186/s12906-017-1567-9.
- Latif, A., K. Ashiq, M. Qayyum, S. Ashiq, E. Ali and I. Anwer (2019). Phytochemical and pharmacological profile of the medicinal herb: Bryophyllum pinnatum. JAPS: J. Anim. Plant Sci. 29(6): 1528-1534.
- Liou, J. R., M. El-Shazly, Y.C. Du, C.N. Tseng, T. L. Hwang, Y. L. Chuang, Y. M. Hsu, S. L. Chen and M. F. Hou (2013). 1, 5-Diphenylpent-3-en-1-ynes and methyl naphthalene carboxylates from Lawsonia inermis and their anti-inflammatory activity. Phytochem. 88: 67-73. https://doi.org/10.1016/j.phytochem.2012.11.010.
- Malekzadeh, F. (1968). Antimicrobial activity of Lawsonia inermis Appl. Microbiol. 16(4): 663-664. https://doi.org/10.1128%2Fam.16.4.663-664.1968.
- Mastanaiah, J., N. Prabhavathi and B. Varaprasad (2011). Invitro antibacterial activity of leaf extracts of Lawsonia inermis. Int. J. PharmTech. Res. 3(2): 1045-1049.
- Muhammad, H. and S. Muhammad (2005). The use of Lawsonia inermis(henna) in the management of burn wound infections. Afr. J. Biotech. 4(9).
- Munir, M. U., M. A. Saeed, Z. Masood, N. Aslam, U. Farooq and M. Farooq (2022). Analgesic and anti-diabetic potential of Roystonea regia. Int. J. Integ. Health Sci. 3(2): 3-14. https://doi.org/10.56536/ijpihs.v3i2.47.
- Mura, M., R. Saidi, A. Wolf, J. Moalic and M. Oliver (2009). Congenital hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency. Med. Trop. 69(6): 551-555.
- Nayak, B. S., G. Isitor, E. Davis and G. Pillai (2007). The evidence based wound healing activity of Lawsonia inermis Phytother. Res. 21(9): 827-831. https://doi.org/10.1002/ptr.2181.
- Perinet, I., E. Lioson, L. Tichadou, M. Glaizal and L. de Haro (2011). Hemolytic anemia after voluntary ingestion of henna (Lawsonia inermis) decoction by a young girl with G6PD deficiency. Med. Trop. 71(3): 292-294.
- Philip, J. P., G. Madhumitha and S.A. Mary (2011). Free radical scavenging and reducing power of Lawsonia inermis seeds. Asian Pac. J. Trop. Med. 4(6): 457-461. https://doi.org/10.1016/S1995-7645(11)60125-9.
- Pour, A., H. Farahbakhsh and R. Moradi (2018). Assessing effect of climatic-management factors on yield and growth characteristics of henna (Lawsonia inermis) as a medicinal-industrial plant in Kerman province. Agroeco. 10(1): 203-217. https://doi.org/10.22067/jag.v10i1.56222.
- Priya, R., S. Ilavenil, B. Kaleeswaran, S. Srigopalram and S. Ravikumar (2011). Effect of Lawsonia inermis on tumor expression induced by Dalton’s lymphoma ascites in Swiss albino mice. Saudi J. Biol. Sci. 18(4): 353-359. https://doi.org/10.1016/j.sjbs.2011.04.001.
- Qayyum, M., K. Ashiq, S. Tanveer, M. A. Bajwa, A. Shahrukh and N. Jahangir (2020). Review on phytochemical evaluation and extraction of Nigella sativa (Kalongi) with pharmacological and traditional applications. Int. J. Biosci. 16(3): 231-241. http://dx.doi.org/10.12692/ijb/16.3.231-241.
- Qurat-ul-Ain, S., A. Rukhsana, S. I. Tariq and A. Kanwal (2022). Berberis lyceum root bark extract attenuates anticancer drugs induced neurotoxicityand cardiotoxicity in rats. Afr. Health Sci. 22(3): 192-210. https://doi.org/10.4314/ahs.v22i3.22.
- Rahmoun, N., Z. Boucherit-Otmani, K. Boucherit, M. Benabdallah and N. Choukchou-Braham (2013). Antifungal activity of the Algerian Lawsonia inermis (henna). Pharm. Biol. 51(1): 131-135. https://doi.org/10.3109/13880209.2012.715166.
- Raja, W., M. Ovais and A. Dubey (2013). Phytochemical screening and antibacterial activity of Lawsonia inermis leaf extract. Medic. 6(8): 33-36. https://doi.org/10.5829/idosi.ijmr.2013.4.1.6679.
- Rakhshandeh, H., A. Ghorbanzadeh, S. S. Negah, M. Akaberi, R. Rashidi and F. Forouzanfar (2021). Pain-relieving effects of Lawsonia inermis on neuropathic pain induced by chronic constriction injury. Metabol. Brain Dis. 36(7): 1709-1716. https://doi.org/10.1007/s11011-021-00773-w.
- Rekik, D. M., S. B. Khedir, A. Daoud, K. K. Moalla, T. Rebai and Z. Sahnoun (2019). Wound healing effect of Lawsonia inermis. Skin Pharmacol. Physio. 32(6): 295-306. https://doi.org/10.1159/000501730.
- Saeed, S. M. G., S. A. Sayeed, S. Ashraf, S. Naz, R. Siddiqi, R. Ali and M. A. Mesaik (2013). A new method for the isolation and purification of lawsone from Lawsonia inermis and its ROS inhibitory activity. Pak. J. Bot. 45(4): 1431-1436.
- Saghi, A., J. L. Gao, L. Giampietro and E. Amiri-Ardekani (2022). A mechanistic analysis of henna in G6PD deficiency patients. Toxicol. Analyt. et Cliniq. 35(1): 23-32. https://doi.org/10.1016/j.toxac.2022.09.003.
- Sarala, E., M. N. Madhukara, M. Vinuth, Y. R. Reddy and H. Sujatha (2020). Green synthesis of Lawsonia inermis-mediated zinc ferrite nanoparticles for magnetic studies and anticancer activity against breast cancer (MCF-7) cell lines. J. Mater. Sci.: Mater. 31(11): 8589-8596. https://doi.org/10.1007/s10854-020-03394-8.
- Selvanayaki, R and T. Ananthi (2012). Hepatoprotective activity of aqueous extract of Lawsonia inermis against paracetamol induced rats. Asian J. Pharm. Res. 2(2): 75-77.
- Semwal, R. B., D. K. Semwal, S. Combrinck, C. Cartwright-Jones and A. Viljoen (2014). Lawsonia inermis (henna): Ethnobotanical, phytochemical and pharmacological aspects. J. Ethnopharmacol. 155(1): 80-103. https://doi.org/10.1016/j.jep.2014.05.042.
- Sharma, K., R. Saikia, J. Kotoky, J. Kalita and Devi (2011). Antifungal activity of Solanum melongena L, Lawsonia inermis L. and Justicia gendarussa B. against Dermatophytes. Int. J. PharmTech. Res. 3(3): 1635-1640.
- Sharma, R. K., A. Goel and A. Bhatia (2016). Lawsonia inermis Linn: A plant with cosmetic and medical benefits. Internat. J. Appl. Sci. Biotech. 4(1): 15-20.
- Shivsharan, U and Y. Kothari (2020). Antimicrobial activity and isolation of lawsone from Lawsonia inermis using column chromatography. Res. J. Pharmacogn. Phytochem. 12(4): 219-223.
- Siddiqui, B. S., M. N. Kardar, S. T. Ali and S. Khan (2003). Two new and a known compound from Lawsonia inermis. Helv. Chim. Acta, 86(6): 2164-2169. http://dx.doi.org/10.5958/0975-4385.2020.00036.9.
- Soker, M., C. Devecioglu, K. Haspolat, B. Dikicl and O. Dogru (2000). Henna induced acute hemolysis in a G6PD-deficient patient: a case report. Int. J. 15(2): 114-116.
- Suleiman, E. A. and E. A. Mohamed (2014). In vitro activity of Lawsonia inermis (Henna) on some pathogenic fungi. J. Myco. 2014: 1-5. http://dx.doi.org/10.1155/2014/375932.
- Syeda, N. F., G. Hemalatha, T. Smitha and M. Rama (2020). Assessment of neuropharmacological profile of ethanolic extract of Lawsonia inermis Mapana J. Sci. 19(4): 37-48. https://doi.org/10.12723/mjs.55.4.
- Treister-Goltzman, Y., E. Egbaria and R. Peleg (2016). An allergic reaction to henna used in a traditional painting ceremony. Am. J. Trop. Med. Hyg. 94(5): 941. https://doi.org/10.4269/ajtmh.15-0833.
- Tutor, G and C. Watch (2017). Lawsonia inermis-from traditional use to scientific assessment. Afr. J. Pharm. Sci. Pharm. 2(1).
- Wong, K and Y. Teng (1995). Volatile components of Lawsonia inermis flowers. J. Ess. oil Res. 7(4): 425-428. https://doi.org/10.1080/10412905.1995.9698554.
- Yassine, K. A., H. Houari, B. Mokhtar, A. Karim, S. Hadjer and B. Imane (2020). A topical ointment formulation containing leaves’ powder of Lawsonia inermis accelerate excision wound healing in Wistar rats. Vet. World, 13(7): 1280-1287. https://doi.org/10.14202%2Fvetworld.2020.1280-1287.
|